Global Knock Out Mouse Model Market (2021 to 2026) – Growth, Trends, COVID-19 Impact and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Knock out Mouse Model Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering.

The Knock Out Mouse Model Market Size is projected to register a CAGR of 5.2% during the forecast period.

Companies Mentioned

• Charles River Laboratories International Inc.
• Cyagen Biosciences.
• Envigo
• genOway
• Ozgene Pty Ltd.
• Taconic Biosciences, Inc.
• THE JACKSON LABORATORY
• TRANS GENIC INC.

Key Market Trends

Constitutive Knockout Mouse segment Holds Significant Share in Knock out Mouse Model Market

A constitutive Knockout mouse is also called as conventional or whole-body Knockout mouse. A constitutive Knockout mouse is a mouse model in which the target gene is permanently inactivated in the whole animal, in every cell of the organism. This gene inactivation is achieved at all stages of development, from the one-cell embryo stage through adulthood.

A constitutive Knockout mouse is used to determine main functions of the gene or protein, to study human pathologies caused by gene inactivation or deficiency, induce a phenotype to create a disease model or in vivo research tool.

Some of the disadvantages of this model are that it causes embryonic lethality in about 15% of all cases and may modify the animal physiology, adaptation and compensation mechanisms, resulting in false results.

Additionally, strategic initiatives adopting by the market players such as product launches, partnerships and collaborations are likely to drive the segments growth.

North America dominate the Global Knock out Mouse Model Market

North America is expected to dominate the market share with its well-established healthcare infrastructure, better regulatory framework, and government support and presence of many large biotechnological and bio pharmaceutical firms in the developed countries like United States and Canada.

These companies are highly focused on new drug and biologics development, with continuous support from the government in the form of funding from several government bodies and investors, which fuels the growth of this market.

According to the UNESCO Science Report, ‘the USA carries out 46% of global research and development (R&D) in life sciences, making it as the global leader. As R&D activities are increasing, an increased usage of animal models, such as mice, for research is expected.’

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rise in the Advancements of Gene Editing Tools

4.2.2 Growing Research and Development activities by Pharmaceutical and Biopharmaceutical Companies

4.2.3 Rising Demand for Personalized Medicine

4.3 Market Restraints

4.3.1 Alternatives to Animal Testing

4.3.2 Regulations for the Ethical Use of Animals

4.4 Porter’s Five Force Analysis

5 MARKET SEGMENTATION

5.1 By Type

5.1.1 Constitutive Knockout Mouse

5.1.2 Conditional Knockout Mouse

5.1.3 Protein Function Knockout Mouse

5.2 By Application

5.2.1 Oncology

5.2.2 Neurology

5.2.3 Cardiovascular

5.2.4 Other Applications

5.3 By End-User

5.3.1 Clinical Research Organizations

5.3.2 Pharma & Biotechnology Companies

5.3.3 Others

5.4 Geography

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/o47fhb

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900